Navigation Links
Drug Helps Asians Battling Liver Cancer
Date:12/17/2008

Sorafenib boosts survival, even when tumor is linked to hepatitis B, researchers say

TUESDAY, Dec. 16 (HealthDay News) -- The drug sorafenib increased overall survival in Asian-Pacific patients with advanced liver cancer, according to the results of a study that included 226 patients in China, South Korea and Taiwan.

The 150 patients in the treatment group received 400 milligrams of sorafenib (Nexavar) twice a day in six-week cycles, while those in the control group received a placebo.

Median overall survival was 6.5 months for those in the treatment group and 4.2 months for those in the control group. The study also found that sorafenib prolonged the time to progression and disease control rate.

Side effects among those taking the drug included skin reactions on the hands and feet, diarrhea and fatigue. The findings appear online and in the January print issue of The Lancet Oncology.

Sorefenib has been approved in Europe and the United States for treatment of advanced liver cancer, but approval in China was dependent on results from a study in Asian-Pacific patients, who account for 75 percent of liver cancer cases worldwide, according to background information in the study. Liver cancer is associated with chronic infection with hepatitis B (HBV), which is common in the Asian-Pacific region. Many patients are diagnosed when they have advanced liver cancer, which means that surgery is an option for only 20 percent of patients.

"Although other studies suggest that sorafenib might be less efficacious in patients with HBV, we do not agree with these conclusions, and believe that the large proportion of patients with HBV enrolled in our study supports the efficacy of sorafenib in this important patient population," wrote Dr. Ann-Lii Cheng, of the National Taiwan University Hospital, and colleagues.

More information

The American Liver Foundation has more about liver cancer.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, Dec. 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Give Your Heart a Holiday: Eating Almonds Helps Support Healthy Fat Levels
2. Rotary Action Group Helps Launch Major Public-Private HIV Prevention Initiative in Kenya
3. Music Therapy Helps Relieve Anxiety, Emotions of Cancer Diagnosis
4. Combo Therapy Helps Multiple Myeloma Patients
5. Ultrasound Screening Helps Prevent Stroke in Children With Sickle Cell Disease
6. BCBSNC Helps Customers Fight Recession With Free Generics
7. Integrated Benefits Institute Helps Employers Make the Business Case for Health and Productivity Improvement
8. Dismissed leukemia drug helps cll patients, studies show
9. Belmont(R) Rapid Infuser Helps Save Officers Life
10. Treating sleep apnea in Alzheimers patients helps cognition
11. WHO tool helps target bone treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Helps Asians Battling Liver Cancer
(Date:4/24/2017)... DC (PRWEB) , ... April 24, 2017 , ... The ... recognized during ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on ... Santana Telehealth Project for using telemedicine to improve the lives of the poor and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... ... 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer dental clinic, ... people during the April 22-23 event at the San Mateo Event Center. , ... to care, CDA Cares educates the public and policymakers about the importance of good ...
(Date:4/24/2017)... Houston (PRWEB) , ... April 24, 2017 , ... The ... an innovative technology that allows anyone, anywhere to track their cognitive health, and share ... to check their own brain health on the museum's website. , BrainCheck founder, Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a ... products are now available for purchase on RevNutrition.com, a popular website specializing in sales ... produced and popularized in ancient India and Siam. It spread across Asia and Africa ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: